About Signadori Bio
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Paris, France
Tracked Since
Oct 2, 2026
Web & Domain Identity
Official Website
signadoribio.com
Domain Registered Date
Mar 6, 2025
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $12,937,100 · Seed
Ventureburn
- Milestone
Website domain registered
signadoribio.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Signadori Bio.
Funding History
Seed
· May 6, 2026
$12,937,100 Ventureburn
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026